Tracleer and Victoza drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Tracleer (bosentan) and Victoza (liraglutide). Common drug interactions include joint swelling among females and fluid retention among males.

The phase IV clinical study analyzes what interactions people have when they take Tracleer and Victoza. It is created by eHealthMe based on reports of 25 people who take the same drugs from the FDA, and is updated regularly.

What is Tracleer?

Tracleer has active ingredients of bosentan. It is often used in primary pulmonary hypertension. eHealthMe is studying from 55,125 Tracleer users. Check the latest studies of Tracleer.

What is Victoza?

Victoza has active ingredients of liraglutide. It is often used in diabetes. eHealthMe is studying from 42,880 Victoza users. Check the latest studies of Victoza.



On Jul, 27, 2026

25 people who take Tracleer and Victoza together, and have interactions are studied.

Tracleer and Victoza drug interactions.

What are the common drug interactions of Tracleer and Victoza, by gender? *:

female:

  1. Joint swelling
  2. Lumbar spinal stenosis (a medical condition in which the spinal canal narrows and compresses the spinal cord and nerves at the level of the lumbar bone)
  3. Macular degeneration (painless eye condition that leads to the gradual loss of central vision)
  4. Muscular weakness (muscle weakness)
  5. Myocardial infarction (destruction of heart tissue resulting from obstruction of the blood supply to the heart muscle)
  6. Myoclonus (a brief, involuntary twitching of a muscle or a group of muscles)
  7. Nail avulsion (trauma to the nail can cause the nail plate to be torn from the nail bed)
  8. Nail infection
  9. Oedema peripheral (superficial swelling)
  10. Orthostatic hypotension (a medical condition consisting of a sudden decrease in blood pressure when a person stands up)

male:

  1. Fluid retention (an abnormal accumulation of fluid in the blood)
  2. Gastric bypass
  3. Splenic haemorrhage (bleeding from spleen)
  4. Ulcer haemorrhage (bleeding ulcer)
  5. Atrial fibrillation (fibrillation of the muscles of the atria of the heart)
  6. Cardiac arrest
  7. Chronic obstructive pulmonary disease (a progressive disease that makes it hard to breathe)
  8. Pneumonia
  9. Poor venous access
  10. Urinary incontinence (inability to control the flow of urine and involuntary urination)

What are the common drug interactions of Tracleer and Victoza, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

  1. Amnesia (deficit in memory caused by brain damage, disease, or psychological trauma)
  2. Asthma
  3. Concussion (short loss of normal brain function in response to a head injury)
  4. Confusional state
  5. Critical illness polyneuropathy
  6. Diplopia (double vision)
  7. Dysgraphia (impaired ability to learn to write)
  8. Dyspnoea (difficult or laboured respiration)
  9. Fall
  10. Gait disturbance

30-39:

  1. Back pain
  2. Diarrhoea
  3. Dyspepsia (indigestion)
  4. Malaise (a feeling of general discomfort or uneasiness)
  5. Nausea (feeling of having an urge to vomit)
  6. Pain
  7. Pain in extremity
  8. Palpitations (feelings or sensations that your heart is pounding or racing)
  9. Vomiting

40-49:

n/a

50-59:

  1. Anaemia (lack of blood)
  2. Atrial fibrillation (fibrillation of the muscles of the atria of the heart)
  3. Faeces discoloured
  4. Haemorrhage (bleeding)
  5. Poor venous access
  6. Uterine cancer
  7. Fluid retention (an abnormal accumulation of fluid in the blood)
  8. Gastric bypass
  9. Gastric haemorrhage (bleeding stomach)
  10. Gastritis (inflammation of stomach)

60+:

  1. Pneumonia
  2. Dyspnoea (difficult or laboured respiration)
  3. Chronic obstructive pulmonary disease (a progressive disease that makes it hard to breathe)
  4. Coronary artery bypass
  5. Coronary artery occlusion (complete obstruction of blood flow in a coronary artery)
  6. Dehydration (dryness resulting from the removal of water)
  7. Hand fracture
  8. Headache (pain in head)
  9. Hypoxia (low oxygen in tissues)
  10. Influenza

What are the existing conditions these people have? *

  1. Pulmonary Hypertension (increase in blood pressure in the lung artery): 3 people, 12.00%
  2. Essential Hypertension (primary hypertension): 3 people, 12.00%
  3. Type 2 Diabetes: 2 people, 8.00%

* Approximation only. Some reports may have incomplete information.

Do you take Tracleer and Victoza?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Tracleer and Victoza:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Tracleer:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Victoza:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Tracleer and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Victoza and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on bosentan and liraglutide (the active ingredients of Tracleer and Victoza, respectively), and Tracleer and Victoza (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: